What is the appropriate melatonin dose for a healthy 19‑year‑old who wants to use it to aid sleep?

Melatonin Dosing for a 19-Year-Old

For a healthy 19-year-old using melatonin to aid sleep, start with 0.3 to 1 mg taken 1.5 to 2 hours before desired bedtime, with a maximum effective dose of 3-5 mg if needed.

Dose Selection

The evidence strongly supports starting low and titrating up only if necessary:

• Physiologic dosing (0.3-1 mg) is sufficient to raise serum melatonin to normal nocturnal levels and facilitate sleep onset without altering sleep architecture 1, 2
• Research demonstrates that 0.3 mg given 2-4 hours before bedtime significantly decreased sleep onset latency in healthy young adults without causing hangover effects 1
• A 2024 dose-response meta-analysis found that melatonin's sleep-promoting effects peak at 4 mg/day, with diminishing returns beyond this dose 3
• For adolescents/young adults with delayed sleep-wake phase disorder, the AASM guidelines recommend 3-5 mg based on moderate-quality evidence 4

Timing is Critical

Administer 1.5-3 hours before desired bedtime for optimal circadian phase-shifting effects:

• The melatonin phase response curve shows that evening dosing (before the dim light melatonin onset) advances sleep timing 4
• Meta-regression analysis confirmed that time between administration and sleep episode is a significant predictor of efficacy, with 3 hours before bedtime being optimal 3
• Taking melatonin too close to bedtime (30 minutes) is less effective than earlier administration 5

Practical Algorithm

1. Start with 0.3-1 mg taken 2 hours before desired bedtime for 1 week
2. If inadequate response, increase to 3 mg at the same timing
3. Maximum dose: 5 mg (higher doses show no additional benefit and may increase side effects)
4. Use immediate-release formulation (not extended-release, which lacks evidence in this population)

Important Caveats

• Not FDA-approved: Melatonin is a dietary supplement in the US with variable bioavailability between brands; look for USP Verification Mark 6
• The 2017 AASM guideline for chronic insomnia recommends against melatonin for primary insomnia in adults (weak recommendation, low evidence) 7, but this applies to chronic insomnia disorder, not circadian rhythm issues or occasional sleeplessness
• Common side effects include drowsiness (28.8%) and headache (25.1%) 8
• Avoid supraphysiologic doses (>5 mg) commonly sold over-the-counter, as they provide no additional benefit and may cause receptor desensitization 2

When Melatonin is Most Appropriate

This 19-year-old would benefit most if they have:

• Delayed sleep-wake phase (difficulty falling asleep at desired bedtime, naturally staying up late)
• Occasional sleeplessness related to schedule changes
• Jet lag or shift work

If the patient has chronic insomnia unrelated to circadian rhythm issues, cognitive behavioral therapy for insomnia should be first-line, not melatonin 7.